Determinant of QT dispersion in patients with hypertrophic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 4, 2003, Pages 819-826

  Kawasaki, Tatsuya ^a,c   Azuma, Akihiro ^a   Kuribayashi, Toshiro ^b   Shiraishi, Hirokazu ^a   Sawada, Takahisa ^a   Sugihara, Hiroki ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kuribayashi Clinic of Cardiology   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Depolarization; Hypertrophic cardiomyopathy; QT dispersion; Repolarization

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART DEPOLARIZATION; HEART LEFT VENTRICLE WALL; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; QT INTERVAL; REPRODUCIBILITY; SUDDEN DEATH; SYNCOPE;

EID: 0037393197     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00145.x     Document Type: Article

References (40)

1. Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63:342-334.
2. Moreno FL, Vallanueva MT, Karagounis LA, et al. Reduction in QT interval dispersion by successful thrombolitic therapy in acute myocardial infarction. Circulation 1994; 90:94-100.
3. Kuo CS, Munakata K, Reedy P, et al. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation 1983; 67:1356-1367.
4. Dritsas A, Sbarouni E, Gilligan D, et al. QT interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992; 15:739-742.
5. Day CP, McComb JM, Cambell RWF. QT dispersion in sinus beats and ventricular extrasystoles in normal hearts. Br Heart J 1992; 67:39-41.
6. Duisterhout JS, May JF, van Herpen G, et al. A computer program for ECG classification according to the Minnesota Code. J Electrocardiol 1977; 10:379-386.
7. Algra A, Tijssen JGP, Roelandt JRTC, et al. QTc prolongation measured by standard 12 lead electrocardiogram is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83:1888-1894.
8. Kautzner J, Yi G, Camm AJ, et al. Short- and long-term reproducibility of QT, QTc and QT dispersion measurement in healthy subjects. PACE 1994; 17:928-937.
9. Wei K, Dorian P, Newman D, et al. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995; 26:859-863.
10. Bogun F, Chan K, Harvey M, et al. QT dispersion in nonsustained ventricular tachycardia and coronary artery disease. Am J Cardiol 1996; 77:256-259.
11. Linker NJ, Colonna P, Kekwick CA, et al. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992; 69:634-636.
12. Priori SG, Napolitano C, Diehl L, et al. Dispersion of the QT intervals: A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994; 89:1681-1689.
13. Suzuki M, Nishizaki M, Arita M, et al. Increased QT dispersion in patients with vasospastic angina. Circulation 1998; 98:435-440.
14. Higham PD, Funiss SS, Cambell RW. QT dispersion and components of the QT interval in ischemia and infarction. Br Heart J 1995; 73:32-36.
15. Loo A, Arendts W, Hohnloser SH. Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 1994; 74:1113-1118.
16. Perkiomaki JS, Koistinen MJ, Yli-Mayry S, et al. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26:174-179.
17. Zareba W, Moss AJ, Cesie SL. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994; 74:550-553.
18. Mirvis DM. Spatial variation of QT intervals in normal persons and patients with acute myocardial infarction. J Am Coll Cardiol 1985; 5:625-631.
19. Bart CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343:327-329.
20. Walling A, Water DD, Miller DD, et al. Long-term prognosis of patients with variant angina. Circulation 1987; 76:990-997.
21. Grimm W, Steder U, Menz V, et al. Clinical significance of increased QT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy. PACE 1996; 19:1886-1889.
22. Pye M, Quinn AC, Cobbe SM. QT interval dispersion: A noninvasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1994; 71:511-514.
23. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 1982; 65:1388-1394.
24. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk. Circulation 1989; 80:1489-1492.
25. McKenna WJ, Deanfield J, Frauqui A, et al. Prognosis in hypertrophic cardiomyopathy: Role of age, and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1984; 47:532-538.
26. Maron BJ, Cecchi F, McKenna WJ. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994; 72:813-18.
27. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cardiomyepathy. Prospective evaluation of therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86:730-740.
28. Maron BJ, Savage DD, Wolfson JF, et al. Prognostic significance of 24-hour ambulatory monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981; 48:252-257.
29. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979; 43:1242-1244.
30. Cui G, Sen L, Sager P, et al. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am J Cardiol 1994; 74:896-900.
31. Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988; 61:83-87.
32. Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995; 92:231-237.
33. Turrini P, Carrode D, Basso C, et al Dispersion of ventricular depolazization-repolarization: A noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiamyopathy. Circulation 2001; 103:3075-3080.
34. Furushima H, Chinushi M, Washizuka T, et al. Role of alpha1-blockade in congenital long QT syndrome: Investigation by exercise stress test. Jpn Circ J 2001; 65:654-658.
35. Dbrowski A, Kramarz E, Piotrowicz R. et al. Predictive power of increased QT dispersion in ventricular extrasystoles and in sinus beats for risk stratification after myocardial infarction. Circulation 2000; 101:1693-1697.
36. Bazett HC. An analysis of the time relationships of the Heart. Heart 1920; 7:353-370.
37. Yi G, Elliott P, McKenna WJ, et al. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 1998; 82:1514-1519.
38. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72:973-976.
39. Bevilacqua LM, Maguire CT, Seidman JG, et al. QT dispersion in alpha-myosin heavy-chain familial hypertrophic cardiomyopathy mice. Pediatr Res 1999; 45:643-647.
40. Miorelli M, Buja G, Melacini P, et al. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol 1994; 45:121-127